Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial

Bibliographic Details
Main Author: Barbuto, José Alexandre Marzagão
Publication Date: 2023
Format: Article
Language: eng
Source: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Download full: https://doi.org/10.3390/cancers15041239
id USP-2_6f6555f071008b0eb276b6129d0b8d0c
oai_identifier_str 003125795
network_acronym_str USP-2
network_name_str Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
repository_id_str 2721
spelling Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trialVACINAÇÃO2023info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://doi.org/10.3390/cancers15041239https:/directbitstream/6d6b37f1-fea3-40ab-85a1-5021e2bfe570/Barbuto, José Alexandre Marzagãoengreponame:Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)instname:Universidade de São Paulo (USP)instacron:USPinfo:eu-repo/semantics/openAccess2025-08-07T17:16:00Z003125795Repositório InstitucionalPUBhttp://www.producao.usp.br/oai/requestopendoar:27212025-08-07T17:16Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial
title Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial
spellingShingle Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial
Barbuto, José Alexandre Marzagão
VACINAÇÃO
title_short Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial
title_full Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial
title_fullStr Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial
title_full_unstemmed Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial
title_sort Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial
author Barbuto, José Alexandre Marzagão
author_facet Barbuto, José Alexandre Marzagão
author_role author
dc.contributor.author.fl_str_mv Barbuto, José Alexandre Marzagão
dc.subject.por.fl_str_mv VACINAÇÃO
topic VACINAÇÃO
publishDate 2023
dc.date.none.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.3390/cancers15041239
url https://doi.org/10.3390/cancers15041239
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https:/directbitstream/6d6b37f1-fea3-40ab-85a1-5021e2bfe570/
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
collection Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
repository.name.fl_str_mv Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) - Universidade de São Paulo (USP)
repository.mail.fl_str_mv
_version_ 1840443228946432000

Similar Items